Investments Ideas and Research - Of Investor, By Investor, For Investor
Stocks, Mutual Funds, Bonds, Debentures, Fixed Deposit, Real Estate

May 28, 2008

Bafna Pharmaceuticals Ltd - IPO

Bafna Pharmaceuticals Ltd


27-May to 30-May 2008

Size (Equity Shares)



Fixed Price Issue

Face Value 

Rs. 10- 

Price Range 

Rs 40 to Rs 40

Market Lot 


Max shares Retails investor can apply at cut off



Cameo Corporate Services Ltd

Registrar's email

Lead Manager 

Keynote Corporate Services Ltd, Ashika Capital Ltd





About the company 

Incorporated: 1995, Engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. Manufactures 126 formulations under various therapeutic segments, such as anti-infective, cholesterol lowering agents, analgesic and antipyretic, antihelmintics, appetite stimulants, cough and cold preparations, antiulcerants anti diabetic, and vitamins.

In 2006, Bafna has set up an 100% EOU unit at Madhavaram for the production of tablets and capsule with a capacity of 6973.20 lacs and 2462.40 lacs. The unit has been WHO GMP certified and also ISO 9000 certified. The products manufactured in this factory caters to the markets of Srilanka, Ghana and Ukraine. Bafna was involved in the execution of contracts for the generic division of M/s. Croslands from the period 1994 to 2001. Bafna was awarded the WHO GMP certification during the year 1995. Presently around 57 products of the company are registered in Srilanka, 4 products in Ukraine, 1 product in Ghana. The company received the Best Supplier award from the Srilankan Government during 2005.


Objects of the Issue

To undertake Brand Building exercise in domestic & international markets;

To part finance the cost of obtaining MHRA approval for Grantlyon unit;

To set up a Research & Development unit at Grantlyon;

To repay high cost debt;

To meet the working capital requirement;

To meet expenses of the Issue in order to achieve the benefits of listing on the Stock Exchanges;

General corporate purposes.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...
© Copyright 2009-12 Powered by Blogger.

© 2007-2012 Investor Souk: Our Research for your USE, All Rights Reserved.

Template by ScreenWritersArena